Abstract
A growing number of patients are referred for fertility preservation treatment (FPT) prior to gonadotoxic therapy. FPT options include embryo (EC), oocyte (OC) and ovarian tissue cryopreservation. Our objective was to examine future utilization of cryopreserved embryos and eggs in females undergoing fertility preservation treatment prior to gonadotoxic therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have